Sangeeta Ballav
Overview
Explore the profile of Sangeeta Ballav including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sonar P, Shaikh K, Ballav S, Basu S, Harer S
Bioinformation
. 2023 Sep;
18(10):974-981.
PMID: 37654845
Tyrosine kinase receptors promote the growth and differentiation of normal breast and malignant human breast cancer cells, known as ERBB receptors. Various ERBB receptors are EGFR/ErbB1 and ErbB2/neu, which get...
2.
Tarannum A, Ballav S, Rao J, Fathima N
Carbohydr Res
. 2023 Jul;
531:108897.
PMID: 37441844
Dermatan sulfate is one of the major glycosaminoglycan (GAG) present in the animal hides, which is a waste/byproduct from meat industry. Efficient utilization of these meat industry wastes is garnering...
3.
Ballav S, Ranjan A, Basu S
Adv Biol (Weinh)
. 2023 Apr;
7(10):e2300037.
PMID: 37042092
Non-small cell lung cancer (NSCLC) has a very low survival rate due to poor response to chemotherapy and late detection. Epithelial to mesenchymal transition (EMT) is regarded as a major...
4.
Ballav S, Bhosale M, Lokhande K, Paul M, Padhye S, Swamy K, et al.
Adv Biol (Weinh)
. 2023 Apr;
7(10):e2300036.
PMID: 37017501
Epithelial-to-mesenchymal transition (EMT) is responsible for driving metastasis of multiple cancer types including lung cancer. Peroxisome proliferator-activated receptor (PPAR)-γ, a ligand-activated transcription factor, controls expression of variety of genes involved...
5.
Ballav S, Lokhande K, Yadav R, Ghosh P, Swamy K, Basu S
Mol Divers
. 2022 Dec;
27(6):2867-2885.
PMID: 36544031
Peroxisome proliferator-activated receptors (PPAR)-α, a ligand-activated transcription factor stands out to be a valuable protein target against cancer. Given that ligand binding is the crucial process for the activation of...
6.
Ballav S, Biswas B, Sahu V, Ranjan A, Basu S
Cells
. 2022 Oct;
11(20).
PMID: 36291082
Peroxisome proliferator-activated receptor-γ (PPAR-γ) has emerged as one of the most extensively studied transcription factors since its discovery in 1990, highlighting its importance in the etiology and treatment of numerous...
7.
Lokhande K, Ballav S, Yadav R, Swamy K, Basu S
J Biomol Struct Dyn
. 2020 Sep;
40(3):971-981.
PMID: 32954977
Peroxisome Proliferator-Activated Receptors-γ (PPAR-γ), a ligand-activated transcription factor, suggested having anti-inflammatory effects by activating the target genes when bound to the ligand. Herein, we examined a conformational analysis of 8708...
8.
Lokhande K, Ballav S, Thosar N, Swamy K, Basu S
J Mol Model
. 2020 Aug;
26(9):242.
PMID: 32816149
Peroxisome proliferator-activated receptors-γ (PPAR-γ), a ligand-activated transcription factor, activated by several ligands like fatty acids (linoleic acid being the most common) or their metabolites, can function as potential therapeutic target...